Search research articles
Contact Us
Filters
Showing results (241-250 of 336) with videos related to
Page
of 34
Sort By:
European Urology
|
November 18, 2021
Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: The CABADOC Trial
Giulia Baciarello, Remy Delva, Gwenaelle Gravis, et al.
The Oncologist
|
December 14, 2024
Safety and quality of life with maintenance olaparib plus bevacizumab in older patients with ovarian cancer: subgroup analysis of PAOLA‑1/ENGOT-ov25
Coline Montégut, Claire Falandry, Saverio Cinieri, et al.
Journal of Geriatric Oncology
|
September 27, 2023
Post-traumatic stress disorder symptoms and quality of life among older patients with cancer during the COVID-19 pandemic
Francois Cherifi, François Gernier, Fabrice Jardin, et al.
European Urology
|
February 25, 2018
Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies
Gwenaelle Gravis, Jean-Marie Boher, Yu-Hui Chen, et al.
Clinical Genitourinary Cancer
|
March 23, 2021
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study
Stéphane Culine, Aude Fléchon, Gwenaelle Gravis, et al.
Breast Cancer Research and Treatment
|
November 24, 2021
Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis
Brent J Small, Marie Lange, Wanting Zhai, et al.
The Lancet. Oncology
|
July 21, 2018
Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial
Michael Friedlander, Val Gebski, Emma Gibbs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 24, 2018
BRAF Inhibition in <i>BRAF</i><sup>V600</sup>-Mutant Gliomas: Results From the VE-BASKET Study
Thomas Kaley, Mehdi Touat, Vivek Subbiah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2016
Volasertib Versus Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: A Randomized Phase II Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire Study
Eric Pujade-Lauraine, Frédéric Selle, Béatrice Weber, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 22, 2023
Posttraumatic Stress Symptoms in Patients With Cancer During the COVID-19 Pandemic: A One-Year Longitudinal Study
Etienne Bastien, Sophie Lefèvre-Arbogast, Justine Lequesne, et al.
Page
of 34
Search research articles
Search
Showing results (241-250 of 336) with videos related to
Sort By:
Page
of 34
European Urology
|
November 18, 2021
Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: The CABADOC Trial
Giulia Baciarello, Remy Delva, Gwenaelle Gravis, et al.
The Oncologist
|
December 14, 2024
Safety and quality of life with maintenance olaparib plus bevacizumab in older patients with ovarian cancer: subgroup analysis of PAOLA‑1/ENGOT-ov25
Coline Montégut, Claire Falandry, Saverio Cinieri, et al.
Journal of Geriatric Oncology
|
September 27, 2023
Post-traumatic stress disorder symptoms and quality of life among older patients with cancer during the COVID-19 pandemic
Francois Cherifi, François Gernier, Fabrice Jardin, et al.
European Urology
|
February 25, 2018
Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies
Gwenaelle Gravis, Jean-Marie Boher, Yu-Hui Chen, et al.
Clinical Genitourinary Cancer
|
March 23, 2021
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study
Stéphane Culine, Aude Fléchon, Gwenaelle Gravis, et al.
Breast Cancer Research and Treatment
|
November 24, 2021
Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis
Brent J Small, Marie Lange, Wanting Zhai, et al.
The Lancet. Oncology
|
July 21, 2018
Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial
Michael Friedlander, Val Gebski, Emma Gibbs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 24, 2018
BRAF Inhibition in <i>BRAF</i><sup>V600</sup>-Mutant Gliomas: Results From the VE-BASKET Study
Thomas Kaley, Mehdi Touat, Vivek Subbiah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2016
Volasertib Versus Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: A Randomized Phase II Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire Study
Eric Pujade-Lauraine, Frédéric Selle, Béatrice Weber, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 22, 2023
Posttraumatic Stress Symptoms in Patients With Cancer During the COVID-19 Pandemic: A One-Year Longitudinal Study
Etienne Bastien, Sophie Lefèvre-Arbogast, Justine Lequesne, et al.
Page
of 34